Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
- $ 2500
- April 2024
- 214 pages
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients with Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [...] Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Anaplastic Large Cell Lymphoma (ALCL), Anemia, Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Blood Cancer, Burkitt Lymphoma, Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), Clear Cell Squamous Cell Carcinoma , Follicular Lymphoma, Graft Versus Host Disease (GVHD), Hairy Cell Leukemia, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Juvenile Myelomonocytic Leukemia (JMML), Kidney Cancer (Renal Cell Cancer), Leukemia, Lymphoblastic Lymphoma, Lymphoma, Mantle Cell Lymphoma, Metastatic Renal Cell Carcinoma, Multiple Myeloma (Kahler Disease), Mycosis Fungoides, Myelodysplastic Syndrome, Myeloproliferative Disorders, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Papillary Renal Cell Carcinoma, Peripheral T-Cell Lymphomas (PTCL), Plasma Cell Neoplasm, Refractory Acute Myeloid Leukemia, Refractory Anemia With Ringed Sideroblasts, Refractory Multiple Myeloma, Relapsed Acute Myeloid Leukemia, Renal Cell Carcinoma, Sezary Syndrome, T-Cell Leukemia, T-Cell Lymphomas, Unspecified B-Cell Lymphomas, Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)